Franklin Resources Inc Enanta Pharmaceuticals Inc Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 25,593 shares of ENTA stock, worth $239,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,593

Previous 26,179 2.24%

Holding current value

$239,038

Previous $339,000 21.83%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.05 - $16.54 $5,889 - $9,692	-586 Reduced 2.24%	25,593 $265,000
Q2 2024 Aug 14, 2024	SELL	$11.43 - $17.02 $32,998 - $49,136	-2,887 Reduced 9.93%	26,179 $339,000
Q1 2024 May 13, 2024	BUY	$10.08 - $17.46 $292,985 - $507,492	29,066 New	29,066 $507,000
Q1 2023 May 12, 2023	SELL	$38.82 - $54.59 $1,203 - $1,692	-31 Reduced 0.62%	4,994 $201,000
Q4 2022 Feb 10, 2023	SELL	$40.77 - $53.73 $38,813 - $51,150	-952 Reduced 15.93%	5,025 $233,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $288,629 - $425,980	5,977 New	5,977 $309,000
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $154,781 - $204,617	-2,761 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$60.19 - $97.37 $166,184 - $268,838	2,761 New	2,761 $206,000
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $22.9 Million - $33.9 Million	-268,025 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $1.45 Million - $2.14 Million	-17,775 Reduced 6.22%	268,025 $31.1 Million
Q1 2018 May 10, 2018	SELL	$57.91 - $92.15 $1.85 Million - $2.94 Million	-31,900 Reduced 10.04%	285,800 $23.1 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $5.37 Million - $6.99 Million	117,700 Added 58.85%	317,700 $18.6 Million
Q3 2017 Nov 13, 2017	BUY	$37.91 - $46.8 $7.58 Million - $9.36 Million	200,000	200,000 $9.36 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Enanta Pharmaceuticals Inc Transaction History